Buying a Pharmacy
Why Searchers Look at Pharmacies
Independent community pharmacy is a large, fragmented market under visible stress, which cuts both ways. NCPA's 2025 Digest counts 18,960 independent locations (about 36% of US retail pharmacies) doing a combined $103 billion, with the average store filling roughly 217 prescriptions a day on $5.4 million of sales. Demand is chronic-medication demand: recurring, local, and referral-fed. Chain closures keep sending patients to independents, and many owners are pharmacists near retirement. The stress is real too: 2024 brought a ten-year low in gross profits, and the margin story below is the whole thesis. One more wall to know: North Dakota alone requires majority pharmacist ownership.
What Pharmacies Trade For
Valuation roundups report averages around 2.45x to 3.38x SDE and 3.6x to 4.75x EBITDA, with revenue multiples quoted near 0.16x to 0.49x; the wide spreads track payer mix and script trends more than size. Two deal shapes exist: a whole-store purchase, and a script-file sale in which a buyer (often another pharmacy) acquires the prescription files and inventory while the location closes. Broker rules of thumb price files per annual prescription; treat them as directional. Inventory is typically counted and paid at cost on top of either structure, and it is large enough to move the total check.
Reimbursement Decides the Margin
A pharmacy's gross margin is set mostly by parties who never enter the store: pharmacy benefit managers and government programs. NCPA reports 52% of independent prescriptions ride Medicare Part D or Medicaid, and 2024 gross profits hit a ten-year low, with some scripts reimbursed below acquisition cost. Industry reporting credits the 2024 Medicare change with moving DIR adjustments to the point of sale, ending the months-later clawbacks, but the compression itself did not reverse. Diligence the margin per script by payer, not the blended number: a store can grow scripts and shrink profit at the same time.
The Script File Is the Asset
What transfers in a pharmacy sale is a book of patients and their refills, and it moves on trust and continuity. Verify the file's trend (script counts, transfers in and out, refill persistence), because a declining file at a strong multiple is an overpriced deal wearing a good year. Continuity of the pharmacist-in-charge matters to both patients and the state board; every state requires one, and the license transfer sequence (state permit, DEA registration, NCPDP and NPI updates, payer contracting) has to be mapped before closing or the store cannot bill. The primary wholesaler agreement carries rebate tiers and purchase commitments worth reading line by line.
What to Verify in Diligence
The record to assemble before the offer holds:
- Gross profit per script by payer, with below-cost reimbursements flagged
- Three years of script counts, transfers in and out, and refill persistence
- PBM network contracts and any audit or clawback history
- The primary wholesaler agreement: rebate tiers, commitments, term
- DEA compliance record and controlled-substance inventory reconciliation
- Inventory count at cost, return-to-stock habits, and expired stock
- Front-end, DME, and compounding revenue shares
Financeability Notes
Pharmacies finance under SBA 7(a), and the $1.1M median acquisition loan in the FOIA data sits squarely in searcher range, but lenders underwrite the reimbursement risk directly: expect questions on payer mix, per-script margin trend, and who the pharmacist-in-charge will be on day one. The seasoned charge-off rate for the industry runs higher than its steady-demand reputation suggests, which is the margin compression showing up in loan files. Inventory wants a working-capital line sized to real days on hand. In North Dakota, confirm the pharmacist-majority ownership structure before anything else is spent.
What the Data Says
Valuation roundups report pharmacies transacting on average at roughly 2.45x to 3.38x SDE, 3.6x to 4.75x EBITDA, and 0.16x to 0.49x revenue; directional ranges, not comps for any specific store.
Source: Pharmacy valuation multiples (Peak Business Valuation)
NCPA's 2025 Digest counts 18,960 independent pharmacy locations (about 36% of US retail pharmacies) in a $103 billion market, averaging $5.41 million in annual sales and roughly 217 prescriptions a day, with 52% of scripts under Medicare Part D or Medicaid and 2024 gross profits at a ten-year low.
Source: NCPA, 2025 Digest Report
North Dakota is the only state requiring pharmacies to be majority-owned by licensed pharmacists (a 1963 law voters kept in place by defeating 2014's Measure 7), so a non-pharmacist buyer needs a compliant structure or a different state.
Enter earnings to apply this industry's cited band.
A sanity check against asking prices, not a valuation.
Holding a live deal in this industry? Underwrite it with the comps, cited band, and charge-off rate pre-loaded.
Compare bands across industries in the cited multiple bands by industry.
Who Else Is Buying in This Industry
No consolidator is confirmed in this trade from a primary source. Silence means unverified, not uncontested: check the current list before assuming a quiet market.
The Buyers profiles every confirmed firm, and Who Is Buying in Your Industry maps them trade by trade.
How Big This Market Is
There are about 41,792 businesses in this industry. 34,046 of them (81%) have 5 to 99 employees: the band big enough to have something to sell and small enough to finance. Most of the rest are owner-operators with a job rather than a business to hand over.
Census County Business Patterns (2023). How often they change hands, and where they concentrate, is in Market Depth.
How Often These Loans Go Bad
Of the 136 SBA acquisition loans in this industry that are old enough to have failed, 4 were charged off: a rate of 2.94%. Across every industry we can measure, the pooled rate is 3.51%, so this one runs cooler than the average acquisition.
Computed from SBA loan-level data on a seasoned cohort. It counts loans already written off, so read it as a floor and as a ranking. Every industry's rate.
The Numbers That Run This Business
- Scripts filled per day, new versus refill
- Gross profit per script by payer
- Scripts reimbursed below acquisition cost
- Transfers in and out of the file
- Front-end and DME sales share
- Inventory days on hand at cost
Where to Go Next
Get New Guides by Email
More industries are in research. Leave your email to receive each guide as it publishes.